| |
| |
|
| Insider
Information: |
Einhorn Andrew J. |
| Relationship: |
Chief Financial Officer |
| City: |
Cedar Knolls |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
184,696 |
|
|
Indirect Shares
|
106,444 |
|
|
| Direct
Value |
$21,767 |
|
|
|
Indirect Value
|
$42,097 |
|
|
| Total
Shares |
291,140 |
|
|
| Total
Value |
$63,864 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PDS Biotechnology Corp |
PDSB |
Chief Financial Officer |
2017-03-01 |
43,223 |
2017-03-01 |
83,592 |
Premium* |
|
|
Osmotica Pharmaceuticals Plc |
OSMT |
Chief Financial Officer |
2022-01-24 |
141,473 |
2022-01-24 |
22,852 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OSMT |
Osmotica Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2022-01-24 |
4 |
D |
$1.13 |
$10,856 |
D/D |
(9,607) |
141,473 |
0 |
- |
|
| OSMT |
Osmotica Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2021-05-18 |
4 |
D |
$3.12 |
$20,177 |
D/D |
(6,467) |
151,080 |
0 |
- |
|
| OSMT |
Osmotica Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2021-01-24 |
4 |
D |
$4.46 |
$43,119 |
D/D |
(9,668) |
157,547 |
0 |
- |
|
| OSMT |
Osmotica Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2020-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
71,550 |
167,215 |
0 |
- |
|
| OSMT |
Osmotica Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2020-01-28 |
4 |
D |
$7.00 |
$64,288 |
D/D |
(9,184) |
95,665 |
0 |
- |
|
| OSMT |
Osmotica Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2019-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
104,849 |
104,849 |
0 |
- |
|
| PDSB |
PDS Biotechnology Corp |
Chief Financial Officer |
• • – |
2017-03-01 |
4 |
OE |
$2.39 |
$3,745 |
D/D |
1,567 |
43,223 |
0 |
- |
|
| PDSB |
PDS Biotechnology Corp |
Chief Financial Officer |
• – – |
2015-10-06 |
4 |
A |
$7.75 |
$12,795 |
I/I |
1,651 |
83,592 |
0 |
- |
|
| PDSB |
PDS Biotechnology Corp |
Chief Financial Officer |
• – – |
2015-10-06 |
4 |
B |
$11.00 |
$495,000 |
I/I |
45,000 |
81,941 |
1.99 |
- |
|
| PDSB |
PDS Biotechnology Corp |
Chief Financial Officer |
• – – |
2015-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
36,941 |
36,941 |
0 |
- |
|
| PDSB |
PDS Biotechnology Corp |
Chief Financial Officer |
• – – |
2015-10-06 |
4 |
A |
$6.79 |
$16,140 |
D/D |
2,377 |
41,656 |
0 |
- |
|
| PDSB |
PDS Biotechnology Corp |
Chief Financial Officer |
• – – |
2015-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
39,279 |
39,279 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
